IP Library › Granted Patent US 10,288,602
Granted Patent B2
US 10,288,602 · App. 15/727,851 · Granted May 14, 2019

Screening method, a kit, a method of treatment and a compound for use in a method of treatement

Inventor: Tore Bengtsson (Vaxholm, SE)
Assignee: ATROGI AB
G01N33/5023A61K31/713G01N33/5008G01N33/566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,288,602
App. No.
15/727,851
Granted
May 14, 2019
Kind
B2
Abstract

A method of screening for a candidate compound for the treatment of a condition involving dysregulation of metabolism in a mammal, said method comprising bringing a compound into contact with at least one population of cells, comprising cells that express mTOR and Akt and that are capable of activating mTORC2 and Akt; determining mTORC2 activity and Akt activity in cells brought into contact with the compound, and identifying the candidate compound based on the determined mTORC2 activity and Akt activity. A kit for use in such a method of. A compound for use in a method of treatment of a condition involving dysregulation of metabolism in a mammal, and a method of treatment of such a condition.

Claims (2)

1. A method of treatment or prevention of a condition involving a dysregulation of glucose homeostasis or glucose uptake in a human, comprising administering, to a human in need of such treatment, a therapeutically effective amount of clenbuterol.

2. The method of claim 1 , wherein the condition is diabetes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2018
From: BENGTSSON, TORE
To: ATROGI AB
Reel/Frame 044652/0364 →
Continuity (3)
Division 14759572
Provisional Application 61750121 · Jan 8, 2013
Related Publication 20180095072A1 · Apr 5, 2018
Cited By (2)
US 12,280,023 US 12,378,216